CVKD - CIK 0001937993
Cadrenal Therapeutics, Inc. has filed 237 documents with the SEC between 2022 and 2026. The most frequent type is major company event (50 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2025-10-03 | 2025-10-02 |
| Insider sale notice | 144 | 2025-10-02 | - |
| Insider sale notice | 144 | 2025-10-01 | - |
| Insider sale notice | 144 | 2025-10-01 | - |
| Insider trade | 4 | 2025-10-01 | 2025-09-29 |
| Insider trade | 4 | 2025-10-01 | 2025-09-29 |
| Insider sale notice | 144 | 2025-09-29 | - |
| Insider sale notice | 144 | 2025-09-29 | - |
| 144/A | - | 2025-09-29 | - |
| Insider trade | 4 | 2025-09-26 | 2025-09-24 |
| Insider trade | 4 | 2025-09-26 | 2025-09-24 |
| Insider sale notice | 144 | 2025-09-25 | - |
| Insider sale notice | 144 | 2025-09-25 | - |
| Insider sale notice | 144 | 2025-09-24 | - |
| Insider sale notice | 144 | 2025-09-24 | - |
| Major company event | 8-K | 2025-09-24 | 2025-09-24 |
| Major company event | 8-K | 2025-09-15 | 2025-09-12 |
| Insider trade | 4 | 2025-08-29 | 2025-08-27 |
| Insider trade | 4 | 2025-08-29 | 2025-08-27 |
| Insider sale notice | 144 | 2025-08-28 | - |
| Insider sale notice | 144 | 2025-08-28 | - |
| 144/A | - | 2025-08-27 | - |
| Insider sale notice | 144 | 2025-08-27 | - |
| Insider sale notice | 144 | 2025-08-27 | - |
| Major company event | 8-K | 2025-08-11 | 2025-08-11 |
| Quarterly report | 10-Q | 2025-08-11 | 2025-06-30 |
| Major company event | 8-K | 2025-08-05 | 2025-08-05 |
| Annual report to shareholders | ARS | 2025-07-31 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-07-31 | - |
| Proxy statement | DEF 14A | 2025-07-31 | 2025-09-24 |
| Major company event | 8-K | 2025-07-18 | 2025-07-15 |
| Major company event | 8-K | 2025-05-08 | 2025-05-08 |
| Quarterly report | 10-Q | 2025-05-08 | 2025-03-31 |
| Major company event | 8-K | 2025-04-17 | 2025-04-17 |
| Prospectus supplement | 424B5 | 2025-04-17 | - |
| Insider trade (amended) | 4/A | 2025-03-24 | 2025-01-23 |
| Major company event | 8-K | 2025-03-13 | 2025-03-13 |
| Annual report | 10-K | 2025-03-13 | 2024-12-31 |
| Major company event | 8-K | 2025-03-04 | 2025-03-03 |
| SCHEDULE 13G/A | - | 2025-02-12 | - |
| Major company event | 8-K | 2025-02-07 | 2025-02-04 |
| Insider trade | 4 | 2025-02-06 | 2025-02-05 |
| New insider ownership | 3 | 2025-02-06 | 2025-02-05 |
| Employee stock plan | S-8 | 2025-02-03 | - |
| SCHEDULE 13D | - | 2025-01-29 | - |
| Insider trade | 4 | 2025-01-24 | 2025-01-23 |
| Insider trade | 4 | 2025-01-24 | 2025-01-23 |
| Insider trade | 4 | 2025-01-24 | 2025-01-23 |
| Insider trade | 4 | 2025-01-24 | 2025-01-23 |
| Insider trade | 4 | 2025-01-24 | 2025-01-23 |